Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Gary › NPI 1467504555
Hospital

The Methodist Hospitals, INC

The Methodist Hospitals, INC was paid $75.57M by Medicaid between Jan 2018 and Dec 2024, across 260 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoTHE METHODIST HOSPITALS, INC
GARY, IN 46402
33aNPI1467504555assigned 01/17/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$75.57M
24GClaims1,415,134
24DCodes billed260
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Indiana

Rank by total paid#3 of 69
Median peer was paid$9.76M
This provider vs. median7.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018170,065$2.42M
2019159,373$6.82M
2020151,735$8.00M
2021195,013$11.19M
2022262,287$16.94M
2023281,940$18.64M
2024incomplete194,721$11.57M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 71,171 62,450 $10.89M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.3% 44,281 37,734 $7.05M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.5% 36,931 31,489 $6.41M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.5% 44,171 40,002 $5.68M
71045 Radiologic examination, chest; single view 6.3% 33,598 28,804 $4.76M
99218 5.6% 12,275 5,351 $4.25M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 5.3% 5,748 2,413 $3.98M
J9271 Injection, pembrolizumab, 1 mg 3.9% 660 367 $2.97M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.5% 39,163 33,698 $2.65M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.6% 20,733 4,097 $1.99M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.1% 22,261 19,450 $1.56M
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.0% 22,793 19,955 $1.48M
248 more codes
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.9% 12,740 $1.44M
99221 1.8% 3,117 $1.34M
59025 Fetal non-stress test 1.5% 4,250 $1.17M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.3% 2,724 $1.01M
99213 Doctor's office visit, returning patient (routine) 1.2% 7,467 $893K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.1% 6,691 $855K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 34,805 $807K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.0% 4,179 $775K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 36,793 $719K
70450 Computed tomography, head or brain; without contrast material <1% 7,196 $709K
71046 Radiologic examination, chest; 2 views <1% 8,608 $704K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 607 $676K
99214 Doctor's office visit, returning patient (more involved) <1% 5,807 $656K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 137,011 $570K
J2323 Injection, natalizumab, 1 mg <1% 100 $524K
80053 Comprehensive metabolic panel <1% 89,402 $507K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 10,164 $488K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 15,548 $419K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 15,549 $419K
J0897 Injection, denosumab, 1 mg <1% 1,174 $417K
80050 General health panel <1% 2,307 $381K
36415 Collection of venous blood by venipuncture <1% 185,857 $354K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 6,882 $352K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 260 $290K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 585 $289K
84484 <1% 31,066 $205K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 9,223 $195K
J1756 Injection, iron sucrose, 1 mg <1% 3,731 $189K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 420 $176K
99217 <1% 952 $160K
96367 <1% 3,076 $158K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,499 $156K
81025 <1% 31,554 $156K
96361 Intravenous infusion, hydration; each additional hour <1% 11,317 $150K
96417 <1% 1,375 $143K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 820 $135K
80048 Basic metabolic panel (calcium, ionized) <1% 28,442 $122K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,039 $121K
96375 Therapeutic injection; each additional sequential IV push <1% 22,109 $121K
96415 <1% 1,276 $115K
80061 Lipid panel <1% 11,579 $105K
J3111 Injection, romosozumab-aqqg, 1 mg <1% 205 $105K
73562 <1% 2,157 $94K
76819 Fetal biophysical profile; without non-stress testing <1% 1,777 $90K
77067 Screening mammography, bilateral, including computer-aided detection <1% 590 $88K
80074 <1% 1,978 $78K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,616 $70K
81001 <1% 34,388 $65K
64483 <1% 170 $63K
83036 Hemoglobin; glycosylated (A1C) <1% 8,709 $60K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 5,498 $60K
83735 <1% 15,375 $59K
83690 <1% 17,963 $59K
84443 Thyroid stimulating hormone (TSH) <1% 6,275 $59K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,870 $57K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 191 $57K
82607 <1% 6,472 $55K
97161 <1% 460 $53K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 376 $52K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,843 $50K
73565 <1% 1,202 $47K
82728 <1% 6,185 $46K
82746 <1% 5,643 $46K
84466 <1% 6,314 $44K
83880 <1% 2,201 $43K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,183 $43K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,594 $42K
99215 Doctor's office visit, returning patient (complex) <1% 379 $41K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 67 $38K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,684 $38K
86703 <1% 3,200 $37K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 212 $35K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 905 $33K
93017 <1% 183 $33K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 44 $31K
43235 <1% 13 $30K
71047 <1% 1,142 $28K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 15 $28K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,504 $27K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 443 $27K
76830 Ultrasound, transvaginal <1% 149 $26K
11045 <1% 106 $26K
73130 <1% 575 $25K
84702 <1% 3,004 $24K
83550 <1% 2,971 $24K
77063 Screening digital breast tomosynthesis, bilateral <1% 588 $24K
72125 Computed tomography, cervical spine; without contrast material <1% 126 $22K
99204 Doctor's office visit, new patient (more involved) <1% 194 $21K
11043 <1% 44 $20K
73630 <1% 480 $20K
86704 <1% 1,929 $20K
76820 <1% 481 $19K
96411 <1% 364 $18K
86706 <1% 1,958 $18K
72100 <1% 1,060 $18K
87631 <1% 120 $15K
77336 <1% 101 $14K
86696 <1% 887 $14K
87070 <1% 2,239 $14K
86300 <1% 1,143 $13K
73110 <1% 214 $13K
86592 <1% 3,643 $13K
76801 <1% 75 $12K
73030 <1% 347 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 283 $12K
82378 <1% 1,119 $11K
84439 <1% 1,875 $10K
86695 <1% 927 $10K
95885 <1% 35 $10K
83655 <1% 745 $9K
86803 <1% 747 $9K
86694 <1% 731 $9K
84703 <1% 1,553 $8K
87210 <1% 2,543 $8K
72082 <1% 116 $7K
80081 <1% 118 $7K
80069 <1% 1,821 $7K
97162 <1% 84 $7K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,161 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 15 $6K
72040 <1% 130 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 401 $5K
97116 <1% 1,241 $5K
81003 <1% 3,894 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 29 $5K
99203 Doctor's office visit, new patient (routine) <1% 43 $4K
73610 <1% 119 $4K
82784 <1% 466 $4K
99205 Prolong outpt/office vis <1% 49 $4K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 65 $4K
J2785 Injection, regadenoson, 0.1 mg <1% 74 $3K
86003 <1% 26 $3K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 714 $3K
73523 <1% 42 $3K
72110 <1% 45 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 96 $3K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 24 $3K
73502 <1% 55 $2K
73560 <1% 68 $2K
J9267 Injection, paclitaxel, 1 mg <1% 155 $2K
76881 <1% 13 $2K
83605 <1% 317 $2K
95910 <1% 15 $2K
82977 <1% 388 $2K
83615 <1% 536 $2K
83883 <1% 162 $2K
73564 <1% 35 $2K
85660 <1% 309 $1K
86334 <1% 133 $1K
83970 <1% 99 $1K
76821 <1% 16 $1K
84480 <1% 122 $1K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 106 $1K
85379 <1% 166 $1K
82248 <1% 230 $1K
84550 <1% 390 $1K
J9045 Injection, carboplatin, 50 mg <1% 117 $1K
73140 <1% 20 $1K
J9190 Injection, fluorouracil, 500 mg <1% 307 $1K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 76 $927.20
77417 <1% 32 $859.68
82570 <1% 265 $850.91
82043 <1% 250 $797.19
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 168 $745.84
84153 <1% 52 $681.78
72170 <1% 25 $679.83
85610 <1% 475 $675.84
84156 <1% 264 $664.04
86850 <1% 126 $622.88
86901 <1% 377 $602.81
86900 <1% 378 $602.49
84481 <1% 66 $595.93
84165 <1% 128 $576.41
G0008 Administration of influenza virus vaccine <1% 53 $510.21
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 31,597 $466.18
85730 <1% 143 $463.18
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 712 $416.78
82785 <1% 26 $378.58
85027 <1% 75 $368.79
82533 <1% 28 $316.07
84100 <1% 87 $294.05
86756 <1% 47 $283.32
97010 <1% 89 $277.30
86038 <1% 44 $256.61
92133 <1% 22 $247.77
82950 <1% 66 $245.89
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 583 $243.40
83721 <1% 113 $225.21
85045 <1% 119 $222.38
85007 <1% 76 $220.40
J3490 Unclassified drugs <1% 309 $203.09
87110 <1% 17 $184.32
82962 <1% 102 $181.85
85652 <1% 164 $180.20
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,936 $170.82
87040 <1% 13 $144.48
82330 <1% 38 $122.26
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 11,798 $119.14
87081 <1% 33 $109.69
84436 <1% 20 $105.06
87340 <1% 12 $93.17
86140 <1% 34 $90.52
96368 <1% 1,397 $73.71
82565 <1% 34 $73.68
80051 <1% 18 $64.68
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,408 $61.35
84520 <1% 32 $60.08
82652 <1% 12 $46.10
J2704 Injection, propofol, 10 mg <1% 5,088 $41.31
87176 <1% 26 $35.20
90661 <1% 12 $25.26
90653 <1% 21 $25.26
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,675 $15.17
J2060 Injection, lorazepam, 2 mg <1% 15 $12.47
J7030 Infusion, normal saline solution , 1000 cc <1% 4,759 $4.64
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,530 $2.90
J7120 Ringers lactate infusion, up to 1000 cc <1% 487 $2.53
J3010 Injection, fentanyl citrate, 0.1 mg 0% 3,073 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 2,927 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 785 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 2,254 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 1,043 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 1,184 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 335 $0.00
90674 0% 33 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 42 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 107 $0.00
A9270 Non-covered item or service 0% 221 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 64 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 29 $0.00
88342 0% 153 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 14 $0.00
96376 0% 18 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 27 $0.00
90715 0% 33 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 527 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 84 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 681 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 0% 12 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 92 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 438 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 0% 258 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 23 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 25 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 24 $0.00
76942 0% 27 $0.00
S0028 Injection, famotidine, 20 mg 0% 32 $0.00
76937 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOYLE, MATTHEW (PRESIDENT/CEO)
Same official

Other billing entities under DOYLE, MATTHEW

Full network →
ProviderLocationPaid
The Methodist Hospitals, INCGary, IN$2.18M
The Methodist Hospitals, INC.Merrillville, IN$2.17M
The Methodist Hospitals, INCGary, IN$1.37M
The Methodist Hospitals, INCGary, IN$420K
The Methodist Hospitals, INCGary, IN$172K
The Methodist Hospitals, INCGary, IN$93K
The Methodist Hospitals, INCGary, IN$33K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.